This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher

Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher

  • Tickers in this article:
  • CELG

TheStreet's Jim Cramer says that the biotech space is likely to continue its move higher, as earnings come in stronger-than-expected.

10/24/14 - 12:24 PM EDT

Edwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast

  • Tickers in this article:
  • EW

Edwards Lifesciences (EW) shares are climbing after the company beat analysts third quarter earnings expectations and raised its full year guidance.

10/24/14 - 11:54 AM EDT

Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta

Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta

Biotech columnist Adam Feuerstein answers readers' questions about health care.

10/24/14 - 08:28 AM EDT

Edwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast

Edwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast

  • Tickers in this article:
  • EW

Edwards Lifesciences (EW) shares are climbing after the company beat analysts third quarter earnings expectations and raised its full year guidance.

10/24/14 - 11:54 AM EDT

Eli Lilly Hit By Patent Expirations, Prescription Volume Plunges

  • Tickers in this article:
  • LLY

Eli Lilly lost exclusivity in high profile drugs like Cymbalta and Evista and generic competition brought down the volume of medications doctors prescribed.

10/23/14 - 09:51 AM EDT

3 Momentum Stocks to Watch in Biotechnology for Continued Upside

3 Momentum Stocks to Watch in Biotechnology for Continued Upside

Wednesday was a strong session for a number of stocks, and here are three, in particular, to watch for more upside.

10/23/14 - 03:39 PM EDT

Alcobra Applies Revisionist History to ADHD Drug Study Analysis

Alcobra Applies Revisionist History to ADHD Drug Study Analysis

  • Tickers in this article:
  • ADHD

Alcobra disclose new details about the phase III study of attention-deficit hyperactivity disorder drug candidate which contradict results announced by the company in an Oct. 6 press release.

10/23/14 - 09:26 AM EDT

How Will Eli Lilly (LLY) Stock Be Affected Today By Its Mixed Earnings Report?

How Will Eli Lilly (LLY) Stock Be Affected Today By Its Mixed Earnings Report?

  • Tickers in this article:
  • LLY

Eli Lilly (LLY) reported third quarter earnings below analysts expectations while revenues exceeded forecasts.

10/23/14 - 09:45 AM EDT

Why Biogen Idec (BIIB) Stock Is Tanking Today

Why Biogen Idec (BIIB) Stock Is Tanking Today

  • Tickers in this article:
  • BIIB

Biogen Idec (BIIB) shares are declining after the company confirmed the death of a patient using its multiple sclerosis treatment.

10/22/14 - 12:39 PM EDT

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

U.S. stocks move lower in midday trading on Wednesday on higher than forecast oil inventories released by the Energy Information Administration.

10/22/14 - 02:40 PM EDT

How WIll Intuitive Surgical (ISRG) Stock React to Its Earnings Beat Today?

How WIll Intuitive Surgical (ISRG) Stock React to Its Earnings Beat Today?

  • Tickers in this article:
  • ISRG

Intuitive Surgical (ISRG) shares are down despite beating analysts third quarter revenue and earnings guidance.

10/22/14 - 12:07 PM EDT

Why Thermo Fisher Scientific (TMO) Stock Is Declining Today

Why Thermo Fisher Scientific (TMO) Stock Is Declining Today

  • Tickers in this article:
  • TMO

Thermo Fisher Scientific (TMO) shares are dropping after the company lowered its full year revenue and earnings guidance on Wednesday.

10/22/14 - 10:18 AM EDT

Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results

Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results

But you're getting way ahead of the facts if you think Regulus has a game-changing hepatitis C therapy in its grasp already. There's a lot more questions to be answered.

10/22/14 - 11:52 AM EDT

Why Amgen (AMGN) Stock Is Rising in Afternoon Trading Today

Why Amgen (AMGN) Stock Is Rising in Afternoon Trading Today

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are climbing after an activist hedge fund manager Dan Loeb released a positive letter to investors.

10/21/14 - 03:19 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs